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We describe the internal organization of murine embryoid bodies (EBs) in terms of the structures and
cell types formed as Oct4 expression becomes progressively lost. This is done by making the EBs from
iPS cells carrying a novel Oct4 reporter (Oct4-MerCreMer;mTmG) which is inducible, sensitive, and
permanent in all cellular progeny. When these EBs are treated with tamoxifen, the Oct4 expressing cells
switch from a red to a green ﬂuorescence color, and this is maintained thereafter by all their progeny.
We show that there is no speciﬁc pattern in which Oct4 is downregulated, rather it appears to be
spatially random. Many of the earliest cells to lose Oct4 expression stain positive for markers of visceral
endoderm (DAB2, a-fetoprotein (AFP), HNF4). These are randomly located, although if endoderm
differentiation is allowed to commence before EB formation then an external layer is formed. This is
true both of EBs made from the reporter iPS cells, or from an embryo-derived mouse ES line (R1 cells).
Markers of the early body axis, Brachyury (BRA) and FOXA2, usually showed a concentration of positive
cells in one region of the EB, but the morphology is not predictable and there are also scattered cells
expressing these markers. These patterns are similar in R1 cells. Use of the Oct4 reporter showed a
difference between BRA and FOXA2. BRA, which marks the early mesoderm, node and notochord, arises
in Oct4 expressing cells on days 3–4. FOXA2, which marks the ﬂoor plate of the neural tube and
deﬁnitive endoderm, as well as the node and notochord, arises at the same time but mostly in cells that
have already lost Oct4 expression. Several clumps of cardiomyocytes are visible by days 7–8 of EB
development, both in our iPS cells and in R1 cells. Using the Oct4 reporter we show that the cells
forming these clumps lose Oct4 expression between days 3 and 5. Overall, our results indicate that EBs
recapitulate normal development quite well in terms of the tempo of events and the appearance of
speciﬁc markers, but they do not resemble embryos in terms of their morphology.
& 2012 Elsevier Inc. All rights reserved.Introduction
The embryoid body (EB) is a structure formed by an aggregate
of pluripotent stem cells when they are removed from feeder cells
and plated onto non-adhesive dishes. EBs were originally
described in vivo, arising from teratomatous tumors (Stevens,
1960). EBs formed in vitro were ﬁrst described using teratocarci-
noma cells (Martin et al., 1977). Subsequently they were made
from murine embryonic stem cells (Doetschman et al., 1985;
Keller, 1995; Leahy et al., 1999) and from induced pluripotent
stem cells (iPS cells) (Takahashi and Yamanaka, 2006; Wernig
et al., 2007). Following the discovery of human embryonic stem
cells it was found that these too can form embryoid bodies, as can
human iPS cells (Rust et al., 2006; Thomson et al., 1998; Yu et al.,
2007). Today, the formation of EBs from human ES and iPS cells
is often the ﬁrst step in protocols for directed differentiation toll rights reserved.
).cell types potentially useful for clinical transplantation, such as
pancreatic beta cells, cardiomyocytes or dopaminergic neurons
(Murry and Keller, 2008).
Despite the enormous practical importance of embryoid bodies,
relatively little is known about their internal structure. They are
usually described as being ‘‘like embryos’’ but it is rarely speciﬁed in
which particular regard they resemble, or differ from, normal
embryos. In this paper we describe the internal organization of
murine EBs in terms of the structures and cell types formed as Oct4
expression becomes progressively lost. To do this we have employed
a line of iPS cells made from a mouse containing a knocked-in
Oct4-MerCreMer gene (Greder et al., in press) together with the
mTmG reporter, which is a cassette in which expression of the red
ﬂuorescent protein tdTomato is replaced by enhanced green ﬂuor-
escent protein (EGFP) following Cre mediated DNA excision
(Muzumdar et al., 2007). Treatment of these cells with tamoxifen
will activate the MerCreMer and thereby label all Oct4-expressing
cells with a permanent, membrane bound, GFP label. If the speci-
mens are ﬁxed at a later time, it is possible to determine whether
precursor cells were or were not expressing Oct4 at the time of
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interest are green or red. This is a novel type of Oct4 reporter, which
is superior to the previous reporters because of its high sensitivity
and provision of permanent lineage labeling following the initial
induction.
OCT4 is well known as being the core member of a group of
pluripotency-conferring transcription factors which also
includes SOX2 and NANOG (Niwa, 2007). In the mouse embryo
it is expressed at a high level in the entire early preimplanta-
tion embryo. During expansion of the blastocyst, expression is
enhanced in the inner cell mass and declines in the trophecto-
derm. It continues to be expressed in the primitive endoderm
but is downregulated as this differentiates into visceral and
parietal endoderm. At postimplantation stages, Oct4 is highly
expressed in the epiblast of the egg cylinder stage and becomes
downregulated from the anterior end during gastrulation, and
by the time of somite formation it is lost from all parts of the
embryo except the primordial germ cells (Kehler et al., 2004;
Scholer et al., 1990; Yeom et al., 1996). OCT4 both upregulates
expression of the other transcription factors needed for plur-
ipotency, and represses expression of transcription factors
involved in regional speciﬁcation during embryonic develop-
ment (Bernstein et al., 2006). Knockout of Oct4 has shown that
it is essential for preimplantation development and for the
establishment of embryonic stem cell lines (Nichols et al.,
1998). Conditional knockout has shown that it is essential for
normal germ cell development (Kehler et al., 2004). However,
despite many claims to the contrary, careful examination of
the expression and requirement for Oct4 in postnatal mouse
development indicates that it has no role in the function of
the various types of tissue speciﬁc stem cell other than the
spermatogonia (Lengner et al., 2007).
In this paper we have studied EB development from the
standpoint of identifying which cell populations lose Oct4 expres-
sion at which times. The reporter system allows for two different
types of observation. If tamoxifen is administered and then the EB
is ﬁxed shortly afterwards, this gives a sensitive indication of
those cells currently expressing Oct4. If tamoxifen is adminis-
tered, and then the EBs are kept alive for some days before
ﬁxation, the green color shows which structures are derived from
cell populations that were formerly expressing Oct4 at the time of
the tamoxifen treatment. Both procedures can be useful depend-
ing on the question to be answered.
We have used a standard size of EB and standard culture
conditions in order to maximize reproducibility. Our results show
several interesting things. The ﬁrst cells to lose Oct4 are positive
for markers of visceral endoderm (DAB2, AFP, HNF4). But these
cells are mostly present internally and do not form an outer layer
of endoderm as has been previously reported (Grover et al., 1983).
This is true also of normal mouse ES cells using our culture
methods, and we show that the characteristic external ‘‘rind’’ of
endoderm only arises if differentiation is allowed to commence
before EB assembly takes place.
We ﬁnd that the main axial structures, identiﬁed using anti-
bodies for BRA and FOXA2, arise between day 3 and 4 of EB
differentiation, and although there is often a single major con-
centration of cells there are also many scattered cells expressing
the relevant marker genes. The FOXA2 labeled structures lose
Oct4 expression before the BRA labeled structures. The heart
arises from cells that lose Oct4 expression over days 4–5, and
usually appears as multiple blocks of cardiac muscle.
In general the time course of development of cell types in the
EBs is similar to what is seen in embryos, while the structural
organization is very different. The EBs do not show a large scale
structure similar to embryos, but are more like a mosaic of micro-
regions.Materials and methods
IPS cell culture
Oct4-CreER, mTmG iPS cells (line 3F10, Greder et al., in press)
and R1 murine embryonic stem (ES cells) (Nagy et al., 1993) were
maintained in the undifferentiated state by culturing them on
irradiated embryonic mouse ﬁbroblasts with ES medium (knockout
DMEM: Gibco) supplemented with 10% fetal bovine serum (FBS:
HyClone), 10% knockout serum replacer (Gibco), 1% L-glutamine
200 mM (Gibco), 1% penicillin/streptomycin (Gibco), 1% MEM non-
essential amino acids (Gibco), 0.1 mM 2-Mercaptoethanol (Sigma)
and 1000 Units/ml ESGRO-mLIF (Millipore). Cells were cultured at
37 1C in 5% CO2.
Embryoid body generation and culture
3F10 iPS cells (passage 13–22), or R1 ES cells, were cultured for
48 h in ES medium, and were then dissociated to single cells by
using 0.25% Trypsin-EDTA (Gibco). Cells were re-suspended with
10% FBS high glucose DMEM medium. A feeder depletion was then
carried out by culturing the cells on tissue culture plates for 45 min
in ES medium at 37 1C and 5% CO2. The cells were then counted with
a hemocytometer (Bright-line) and 500 cells/well were dispensed
into 96 well Round Bottom, Ultra-Low Attachment plates (Costar)
then spun at 3000 rpm for 4 min. Embryoid bodies were differen-
tiated using knockout DMEM (Gibco) supplemented with 15% fetal
bovine serum (HyClone), 1% L-glutamine 200 mM (Gibco), 1%
penicillin/streptomycin (Gibco), 1% MEM Non-Essential amino acids
(Gibco) and 0.1 mM 2-Mercaptoethanol (Sigma). The same batch of
fetal bovine serum was used for all the embryoid body differentia-
tion experiments. Predifferentiated EBs were generated from 3F10
iPS cells or R1 ES cells by culturing in gelatin-coated wells for 1 day
with ES medium and 2 further days with ES medium lacking LIF.
Tamoxifen treatment
Stock Tamoxifen 10 mM (Sigma) was diluted using DMSO to
0.1 mM, which was further diluted in growth medium to 100 nM.
Treatment with Tamoxifen was carried out either at the time of
cell aggregation (day 0) or on the indicated day of embryoid body
differentiation. Specimens were ﬁxed for analysis either 12 h
following tamoxifen addition, or at a later time as indicated in
the text.
Immunohistochemistry
EBs were collected from the low attachment 96 well plates and
washed once with PBS (Cellgro) before being ﬁxed with 4% PFA for
5 min at room temperature. EBs were then permabilized for
3 times 30 min with PBS/0.5% Triton (Sigma) (PBS-T), and blocked
for 2 h at RT with 5% normal donkey serum (NDS) in PBS-T.
Fixed EBs were incubated overnight at 4 1C with primary anti-
bodies diluted in blocking buffer. Antibodies were directed
toward OCT4 (SC-9081 1:200; Santa Cruz), Brachyury (SC-17743
1:200 Santa Cruz), FOXA2 (SC-9187 1:200; Santa Cruz), GATA4
(61170 1:500; Abcam), AFP (3H8 1:100; Cell Signaling), Cardiac
Troponin (CT-3C 1:500; DSHB), DAB2/p96 (610464 1:500; BD
Bioscience) and HNF4a (SC-8987 1:200; Santa Cruz). EBs were
washed 3 times with PBS-T for 30 min and re-blocked with
blocking buffer for 2 h at RT. Washed EBs were then incubated
overnight at 4 1C with secondary antibodies. Alexa Fluor 647
donkey anti-mouse IgG (A31571 1:1000; Invitrogen), goat IgG
(A21447 1:1000; Invitrogen) and rabbit IgG (A31573 1:1000
Invitrogen), then washed 3 times with PBS-T for 30 min before
imaging. Processed EBs were placed onto depression slides,
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View FV1000 IX2 inverted confocal microscope with FLIM detec-
tor or Leica DMRB6000 equipped with a Retiga 2000 camera using
IP Lab software. The far red emission color of Alexa Fluor 647 is
here shown in magenta. For cell counting, 100 cells in each of
three similar EBs, stained with the antibody of interest, were
scored as being either red or green.
Quantitative real-time PCR
Total RNA was prepared from 3F10 cells and EBs using the
RNeasy Mini Kit (Qiagen). Genomic DNA was removed from RNA by
DNase (Promega) treatment for 1 h at 37 1C. cDNA was generated by
reverse transcription from 2 mg total RNA using SuperScript III
Reverse Transcriptase, oligo(dT)20 and dNTP (10 mM) (Invitrogen).
Generated cDNA was validated by a 30-cycle PCR beta-actin reac-
tion. Gene expression proﬁles of developing embryoid bodies
included the following genes: Oct4, Brachyury, Foxa2, Sox1, Sox17,
Flk1, Gata4, Gat6, Ctnt, Afp and the housekeeping gene Gapdh. Sorted
cells were analyzed for Oct4, Gata4, Gata6 AFP, Sox17, FGF5 and Cdx2.
All qRT-PCRs were carried out on three biological replicates and
results are indicated as means with error bars. Quantitative RT-PCR
was performed on an Eppendorf lightcycler using IDT predesigned
primers, see Table S1.
Fluorescent activated cell sorting (FACS)
EBs were dissociated using 0.25% Trypsin-EDTA (Gibco) to
single cells and centrifuged at 1000 rpm for 5 min. Cells were
then resuspended in 700 ml of PBS and ﬁltered using 5 ml
polystyrene Round-Bottom Tubes with Cell-strainer Caps (BD
Falcon). For counting, cells were analyzed using the FACS Calibur.
For sorting, tamoxifen treated embryoid bodies were processed
in the same way and cells were separated using the FACS Aria.
RNA from the separated cell samples was isolated using the RNeasy
Mini Kit (Qiagen) and analyzed by qRT-PCR as described above.Fig. 1. Oct4 downregulation during development of embryoid bodies. The pictures
are optical sections through iPS cell EBs. They were labeled by exposure to
tamoxifen at the indicated time and ﬁxed 12 h later. Green (EGFP) indicates
Oct4 expression at the time of treatment, red (tdTom) indicates no Oct4 expres-
sion. (A) Day 0 (i.e. added to the medium during aggregation of the iPS cells).
(B) Day 1. (C) Day 3. (D) Day 4. (E) Day 5. (F) Day 7. Arrows indicate red cells or
patches in (A–C) and green ones in (E, F). Scale bars 100 mm. (G, H) OCT4 protein.
EBs were treated with tamoxifen at day 3, ﬁxed 12 h later, and stained for OCT4.
(G) Green and red ﬂuorescence. (H) OCT4 immunostain (magenta). Arrows are
pointing at red cells in the EB. (I) Flow cytometry of red and green cells from EBs
treated with tamoxifen from day 0 to 7. Treated EBs were left in culture for 24 h
before dissociation and counting.Results
Differentiation of embryoid bodies
EBs were prepared by the spin method (Ng et al., 2005). 500 cells
was chosen as the starting number, hence the initial diameter is
about 9–10 cells. When cultured for one week in differentiation
medium the EBs remain spherical for some days although often
become somewhat irregular by day 7. For spherical EBs, the
diameter increases about 2–2.5 fold during the culture period,
corresponding to an increase of volume, and thereby cell number, of
about 10 fold (Fig. S1).
To establish the location of cells expressing Oct4, EBs were treated
with tamoxifen, commencing on each day of the culture. They were
ﬁxed 12 h later, mounted, and optical sections were recorded by
confocal microscopy. In Fig. 1 are shown optical sections of typical
specimens through the equator. It is known from previous work that
GFP expression becomes visible 4–6 h after administration of the
tamoxifen, and that in vitro the recombination occurs in essentially
100% of the Oct4-expressing cells (Greder et al., in press). The EB
results show that the loss of Oct4 commences from the time of
aggregation but that the red cells are not located on the exterior but
are scattered through the interior of the EB (Fig. 1A). Over the ﬁrst
three days the picture is similar but with small clumps of red cells as
well as scattered individuals (Fig. 1B and C). Although we cannot
prove clonal growth in this situation it seems probable that the
clumps represent clonal growth of the earlier formed red cells. By
three days, the red patches are a bit bigger and some appear on thesurface of the EB (Fig. 1C). By four days about half of the cells have
lost Oct 4 expression (Fig. 1D). It is striking that throughout develop-
ment the distribution of red and green seems completely random,
with no large masses of one color. From day 5 onwards some green
cells persist scattered as small clumps or single cells, but the EB is
predominantly red (Fig. 1E). By day 7, the shape is becoming irregular
and some structures are becoming apparent in the interior. Some
cases, such as that of Fig. 1(F), show an epithelium present around
parts of the exterior, however this is not seen in all cases.
A.A. Sajini et al. / Developmental Biology 371 (2012) 170–179 173To make sure that the green ﬂuorescence really does report
Oct4 expression, we examined day 3 tamoxifen-treated EBs, ﬁxed
after 12 h, by immunostaining for OCT4 protein (Fig. 1G and H).
Typical of a day 3 EB this shows some single red cells and some
small clumps scattered through the specimen. The green cells
correspond very well to the presence, and the red cells to the
absence, of immunostaining for OCT4.
A more quantitative view of the proportion of green and red
cells can be obtained from ﬂow cytometry, shown in Fig. 1I.
The results conﬁrm that the main loss of Oct4 expression occurs
between day 3 and 5, with about equal proportions of green and
red cells being present on day 4. The last two bars shown on this
ﬁgure represent important controls. The ﬁrst of them shows ﬂow
cytometry of day 3 EBs that had been tamoxifen-treated while
they were still iPS cells. Theoretically 100% of cells should be
green. The o1% that are red lost Oct4 expression while still in the
iPSC culture and, as shown below, they do not participate in the
structure of the EB. The second bar shows day 3 EB cells which
were never exposed to tamoxifen. This shows that there is no
background of spontaneous reporter activation over the time
scale of this type of experiment, although there is a low back-
ground during prolonged cell culture in vitro.
We were concerned that the small number of Oct4-negative
cells present in the iPSC cultures before aggregation should not
bias the results. Fig. S2 shows EBs that were established using iPS
cells already treated with tamoxifen, and then cultured for 1,
2 and 3 days before ﬁxation. It may be seen that the small number
of red cells present from the outset are located on the exterior of
the EB. Furthermore their numbers do not increase relative to the
rest of the EB, if anything they are growing more slowly.
In Fig. 2 the expressions are shown of various marker genes
often used for monitoring ES cell differentiation, measured by
quantitative RT-PCR. Antibodies to the protein products of several
of these genes were used for the morphological studies presented
below. The gene expression data over time (Fig. 2A) indicates that
the process of EB differentiation in our system is very similar to
what has been seen many times in murine ES cell differentiation
studies, e.g. (Ensenat-Waser et al., 2006; Mogi et al., 2009;
Sargent et al., 2009). In the ﬁgure the mRNA levels are all
expressed relative to that of Gapdh. Oct4 and Nanog expression,
characteristic of pluripotent cells, fall steadily. Gata4, normally
expressed in primitive, visceral and deﬁnitive endoderm and in
the heart, rises at ﬁrst, then plateaus from day 5. Brachyury (T),
indicative of early mesoderm, rises and falls, peaking at day 4. The
expression of the various other markers: FoxA2 (axial structures),
Sox17 (deﬁnitive endoderm), Flk4 (VEGF receptor, endothelium),
rise continuously over the 7 days period. Cardiac troponin (cTnT), a
terminal differentiation marker for cardiomyocytes, rises steeply
over the last three days. The level of Oct4 expression is still quite
high at the end of the culture period. However the vertical scale is
logarithmic, so the ﬁnal level represents about a 32 fold reduction
from the start, consistent with the presence of perhaps 3% Oct4
positive cells at the end.
Fig. 2B shows gene expression in green and red cells separated
by ﬂow cytometry and then subjected to RNA analysis by
Q-RTPCR. On the left are shown samples treated with tamoxifen
at day 3 and analyzed 12 h later. The 12 h gives time for the full
GFP intensity to develop and so this is a measure of the cells
expressing Oct4 at the time of treatment. As expected, it shows
that the green cells at this stage retain a proﬁle similar to iPS cells.
The main difference between green and red cells is seen for
the Afp and the Sox17, which are respectively about 32 and
16 more abundant in the red cells. This is likely to reﬂect early
formation of visceral and deﬁnitive endoderm. In the immunos-
taining studies presented below, it is shown that AFP protein is
detected in the ﬁrst cells to lose Oct4 expression. On the right sideof the ﬁgure are shown the same measurements conducted on
EBs that were tamoxifen treated at 3 d and then allowed to
develop to 7 d. This means that the green cells are those that
were expressing Oct4 at 3 d, but have subsequently matured for
4 further days, many losing Oct4 expression in the process.
Conversely the red cells are ones that had already lost Oct4 by 3
days and then matured for another 4 days. By 7 days the
expression of all the differentiation markers is higher than at 3
days. Comparing the red and green cells, the Oct4 level is higher
for green cells, probably because there are still some cells
expressing high levels at day 7, and all of these must have been
green at day 3. Also, the Afp level is higher for the red cells
although the absolute level is higher in all cells, probably due to
formation of the liver by this stage. Fig. 2C also illustrates the
perdurance of the tdTomato protein. The left panel shows the
FACS plot 12 h after tamoxifen treatment. At this time the green
cells have the same level of red ﬂuorescence as the red cells
indicating that the tdTomato protein is still present. The right
panel shows the situation 4 days later. Now the green cells have
mostly lost red ﬂuorescence, due to loss of the tdTomato protein.
Formation of extraembryonic endoderm
Based on the knowledge of normal mouse embryo develop-
ment we felt it likely that the ﬁrst cells to lose Oct4 expression
would be those differentiating into extraembryonic endoderm.
We used three markers to analyze this. Disabled-2 (DAB2) is a
cytoplasmic adapter protein that is normally expressed in the
primitive and visceral endoderm, and is necessary for the forma-
tion of the visceral endoderm (Morris et al., 2002; Yang et al.,
2002). Alpha-fetoprotein (AFP) is a secreted protein expressed in
the visceral but not the primitive endoderm (Dziadek and
Adamson, 1978). Hepatic nuclear factor 4 (HNF4) is a nuclear
hormone receptor expressed in the primitive and visceral endo-
derm (Duncan et al., 1994). These markers are expressed in other
cell types later in development but for the ﬁrst three days are
likely indicators of extraembryonic endoderm.
In our EBs, positive immunostain for these three markers is
found in many of the red cells, particularly red cell clumps, of day
3-treated EBs (Fig. 3A–C). For example, 69% (SE 2.9) of AFP cells
were red (Fig. S3). In these EBs there are some surface clumps of
positive cells with an epithelial appearance, but many of the cells
are found scattered through the interior.
Previous accounts of EB formation have often described a layer
of endoderm around the outside and it is usually implied that this
forms very early, as does the primitive endoderm on the blas-
tocoelic surface of the inner cell mass of the mouse embryo. In our
system many of the ﬁrst cells to lose Oct4 expression do express
endoderm markers but are not located at the surface. To ﬁnd if
this was an artifact associated with our speciﬁc iPS cell line, we
repeated the observations on a normal mouse embryo-derived ES
cell line: R1 (Nagy et al., 1993). This gave essentially the same
result, with some surface patches plus many internal endoderm
cells (Fig. 3D–F), indicating that it is not due to an abnormality of
the cells. We then considered whether the culture methods used
in the past may have allowed a degree of pre-differentiation of
extraembryonic endoderm before the EB aggregates were
assembled. To test this we removed LIF from cultures two days
before the spin EBs were made. Tamoxifen was added on the
second day. The spin EBs were further cultured for 3 days. This
procedure gave EBs most of which did have an external layer of
extra-embryonic endoderm composed of mainly red cells, i.e.
those which had ceased to express Oct4 by the time the tamoxifen
was added (Fig. 4A). The red external layer expressed all of the
markers conﬁrming an extraembryonic endodermal character
(Fig. 4B–D). The results from the ES cells were very similar to
Fig. 2. Expressions of key marker genes during EB differentiation. Levels were measured by q-RTPCR and are expressed relative to Gapdh mRNA. The vertical scale is
logarithmic. (A) Gene expression in whole EBs on the indicated days. (B) Gene expression in sorted red and green cells. EBs were tamoxifen treated on day 3 and were
dissociated and sorted either 12 h later (left) or 4.5 days later (right). (C) FACS Aria windows used to isolate red and green cells. Note that the tdTomato is not lost over the
12 h period shown on the left, but does decline in the 4 days period shown on the right.
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ence is much more important than any speciﬁc propensity of the
3F10 line. From these experiments we believe that the previously
reported external endoderm layer in EBs results from a degree of
differentiation prior to the formation of the EBs, and that the layer
will not form if differentiation is strictly prevented until EB
formation.Formation of principal body structures
Primitive streak-like structures have been described in EBs on
occasion (Leahy et al., 1999; Ten Berge et al., 2008). Here we
examined the expression of Brachyury (BRA, also called as T) and
of FOXA2. In the normal mouse embryo, Bra is ﬁrst expressed in
the posterior epiblast, then in the nascent mesoderm of the
Fig. 3. Day 3.5 EBs made from iPS and ES cells. (A–C) are iPS cells with red and green cells shown, as well as an antibody marker of extraembryonic endoderm shown in
magenta. (A, A1) Dab2, (A1) shows an external patch of positive cells, but EBs are frequently like (A). (B, B1) AFP, (C) HNF4. (D–F) are EBs made from R1 mES cells. The blue
is DAPI and antibody staining is green. (D) DAB2, (E) AFP, (F) HNF4. For both iPS and ES cells the extraembryonic endoderm is mostly internal, with some surface patches in
some specimens. Scale bars 100 mm.
Fig. 4. Effects of predifferentiation on the formation of an outer layer of extraembryonic endoderm in EBs. Cells were deprived of LIF for two days before assembly of the EBs.
Tamoxifen was added to label the Oct4-positive cells at the time of EB formation. Specimens are 3 days from EB formation. (A) An iPS EB showing a complete outer layer of red cells.
(B–D) iPS EBs stained with antibodymarkers of extraembryonic endoderm. (B) DAB2, (C) AFP, (D) HNF4. (E–G) ES cell EBs stained with DAPI (blue) and an antibody (green). (E) DAB2,
(F) AFP, (G) HNF4. Scale bars 100 mm.
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late streak. Loss of function mutants show posterior defects
(Wilkinson et al., 1990). Foxa2 is ﬁrst expressed in the anterior
primitive streak, then in the node, the notochord, the ﬂoor plate of
the neural tube, and the deﬁnitive endoderm (Ang et al., 1993;
Sasaki and Hogan, 1993). Loss of function mutants show absence
of the node and notochord (Ang and Rossant, 1994). It is also
active in the anterior visceral endoderm, although not expressed
at high level in this tissue (Kimura-Yoshida et al., 2007).
In our EBs, expression of the BRA protein is evident from day 3.
EBs treated with tamoxifen at day 3 and ﬁxed 12 h later show a
patch of expression on one side of the EB, extending 5–6 cell
diameters internally. There are also a number of scattered BRA-
positive cells. In these specimens, BRA expression is almostentirely in green cells indicating that Oct4 is still expressed
(Fig. 5A and B). EBs treated with tamoxifen at day 4 and ﬁxed
12 h later show some red cells expressing BRA but still mostly
green cells (80% (SE2.3), Fig. S3) (Fig. 5C and D). EBs treated with
tamoxifen at 3 days and ﬁxed 36 h later show virtually all BRA in
green cells (Fig. 5E and F). This means that BRA expression arises
in Oct4-positive cells, and that the Oct4 expression is subse-
quently lost at a slow pace. There is evidence that OCT4 is needed
for the initial expression of BRA (Zeineddine et al., 2006) and our
result is consistent with this although cannot prove it. The story
with FOXA2 is somewhat different. As with BRA, a large patch of
expression is found for EBs treated with TM at 3 days and ﬁxed
12 h later, almost entirely in green cells (Fig. 5G and H). However
in EBs treated with TM at 4 days and ﬁxed 12 h later, the
Fig. 5. FOXA2 cells downregulate Oct4 faster than BRA cells. EBs were treated with tamoxifen at the designated time points and left for 12 h or 36 h before ﬁxation and
immunostaining (magenta). (A, B) Red–green conﬁguration and BRA immunostaining of an EB treated at 3 days and ﬁxed 12 h later. BRA cells are mostly green. Arrows
show selected red cells. (C, D) The same at 4 days. BRA cells are still mostly green. (E, F) BRA in EBs treated on day 3 and ﬁxed 36 h later. BRA is overwhelmingly in green
cells. (G, H) Red–green conﬁguration and FOXA2 immunostaining of an EB treated at 3 days and ﬁxed 12 h later. FOXA2 cells are mostly green. Arrows indicate red patches
lacking FOXA2. (I, J) The same at 4 days, now the FOXA2 cells are mostly red. (K, L) FOXA2 in EBs treated on day 3 and ﬁxed 36 h later. FOXA2 is mostly in green cells, but its
presence in red cells indicates that it can be upregulated in cells that have already lost Oct4. Scale bars 100 mm.
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Fig. S3) (Fig. 5I and J). If EBs are treated with tamoxifen at 3 days
and allowed to develop for 36 h before ﬁxation, then most of the
FOXA2 positive cells are green (Fig. 5K and L). This shows that the
FOXA2 domain cells lost Oct4 expression between 3 and 4 days of
EB development, at about the same time as the commencement of
expression of FOXA2. The presence of FOXA2 in some red cells in
these specimens shows that it is to some extent upregulated in
cells that have already lost Oct4. Between them, the expression
domains of BRA and FOXA2 make up most of the primary body
axis so this study pinpoints the time of its determination in EBs.
However it should be noted that the expression domains in our
EBs are not very coherent. Although a clump of positive cells is
apparent for both markers, there are also many scattered cells
expressing them. Expression patterns of BRA and FOXA2 were
also examined in day 4.5 EBs made from mouse ES cells. They
showed essentially similar patterns to the iPS cells (Fig. S4).
As an example of a terminally differentiated structure arising
early in the development of the normal embryo, we chose the
heart. This can be visualized by expression of the cardiac variant
of troponin T (cTnT), a subunit of troponin, which connects
tropomyosin to actin in the contractile apparatus of cardiac
muscle cells (Fig. 6). By 7–8 days of development, patches of
cTnT-positive cells are clearly visible within the EBs. In EBs
treated with tamoxifen at 3 days and ﬁxed at day 8, the clumps
of cardiac tissue are all green. This is consistent with the
continued expression of Oct4 in the prospective principal bodystructures of this stage, visualized with BRA and FOXA2. In EBs
treated with tamoxifen at 4 days and ﬁxed at 8 days, the cardiac
tissue is mixed red and green. In EBs treated with tamoxifen at 5
days and ﬁxed at 8 days, the cardiac tissue is all red. This shows
that the heart is formed from cells that downregulate Oct4
between 3 and 5 days of EB development, a little later than the
rest of the FOXA2/BRA-positive cell population. The expression
pattern of cTnT in mouse ES cells is similar to that in the iPS cells
(Fig. S4).Discussion
Despite the widespread use of embryoid bodies as a ﬁrst step
in the differentiation of pluripotent stem cells (Keller, 1995;
Murry and Keller, 2008) our knowledge of what actually happens
during EB development is quite limited. They are usually
described as being ‘‘like embryos’’ but without any detail of what
this means. Many previous studies of murine EB structure have
examined them only at the end of a protracted culture period
extending for 10–20 days. In this paper we have analyzed the
development of EBs over a 7 day culture period which includes
the expected time of determination of extraembryonic structures
and the primary body axis. We have done this both by examining
the location of cells bearing certain markers of early developing
cell types and also by using the Oct4-MerCreMermTmG system,
which enables us permanently to label cells that are expressing
Fig. 6. Prospective heart loses Oct4 between d3 and 5. Embryoid bodies were tamoxifen treated at days 3, 4 and 5, and allowed to develop until day 8 before being ﬁxed
and stained for cardiac troponin (magenta). (A) In day 3 treated EBs, all cardiomyocytes arising by day 8 are green. (B) In day 4 treated EBs, cardiomyocytes arise in both
green and red populations of cells. (C) In day 5 treated EBs, all cardiomyocytes arise in red cells. Scale bars 100 mm.
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Muzumdar et al., 2007). We have used a standard size of EB, 500
cells at aggregation, as the size is known to cause differences in
subsequent behavior (Bauwens et al., 2008); and a standard
shape, the sphere, achieved using the spin EB method of forma-
tion (Ng et al., 2005).
Murine ES or iPS cells do not correspond in transcriptional
proﬁle to either the inner cell mass (ICM) or the epiblast of the
normal embryo but are generally considered to resemble the ICM
in developmental properties (Brons et al., 2007; Sato et al., 2003;
Tesar et al., 2007). If they are considered approximately equiva-
lent to the cells of a 3 days mouse ICM, which has lost the ability
to form trophectoderm, then the number of days of EB develop-
ment should correspond to the same number plus 3 days of
mouse embryo development.
Our results enable us to identify the time of loss of Oct4
expression in the future primary body axis as between 3 and
4 days of EB development. This should be compared to between
6 and 7 days of normal embryo development. In normaldevelopment the primitive streak appears about E6.5 and the
head fold about E7.5 (Kaufman and Bard, 1999). The loss of Oct4
over this period in the embryo is similar to its loss from the BRA
and FOXA2 positive cells in our EBs (Osorno et al., 2012). The time
of Oct4 loss that we observe for the future heart, at 3–5 days of EB
development, is a little later than that of the main axial struc-
tures, as might be expected. Although OCT4 is usually considered
as a pluripotency factor, there is evidence that elevated levels are
associated with, or even necessary for, determination of cells to
become mesoderm or more speciﬁcally to become cardiac tissue
(Niwa et al., 2000; Zeineddine et al., 2006). Our results cannot
prove this, but are consistent with a persistent expression of Oct4
in the early stages of development of these structures.
Overall then the tempo of development in our EBs and the timing
of Oct4 loss is similar to normal development. However there are
various respects in which the EBs diverge sharply from normal
development. One is the formation of the primitive endoderm, and
its derivative, the visceral endoderm. The primitive endoderm
appears as a layer on the blastocoelic surface of the ICM in the late
A.A. Sajini et al. / Developmental Biology 371 (2012) 170–179178blastocyst, about 4.5 days. Although there was initially speculation
that it arose as a result of an environmental difference between the
superﬁcial and deep cells of the ICM, it is now known that its
formation is stochastic, with cells that become primitive endoderm
developing spontaneously and sorting out to form the superﬁcial
layer (Chazaud et al., 2006; Plusa et al., 2008). In our EBs we ﬁnd
that most of the ﬁrst cells to lose Oct4 expression arise as single
scattered cells in the interior which do not seem ever to become a
superﬁcial layer. We believe that the frequent observance of an
outer endoderm layer forming in the ﬁrst few days of EB develop-
ment (Abe et al., 1996; Doetschman et al., 1985; Grover et al., 1983;
Leahy et al., 1999) may be due to the presence of signiﬁcant
numbers of cells in the original cultures that had already lost Oct4
and become primitive endoderm. Due to the method of preparation,
our cultures contain virtually none of these, but the very few that
are present do spontaneously sort to the exterior of the aggregates
(Fig. S2). When we deliberately caused some pre-differentiation of
the iPS cells by withdrawing LIF for 2 days before EB formation, then
a large area or even complete circumference of superﬁcial endoderm
was reliably formed.
The rationale for the difference between our EBs and a normal
mouse embryo probably lies in the large size of an EB compared
to the ICM. Studies of EBs of different controlled sizes have shown
that this is a very important variable affecting development
(Bauwens et al., 2008). The normal ICM comprises about 20–40
cells, and the epiblast at the time of implantation about 20–25
cells (Hogan et al., 1994).The growth rate is extremely rapid, with
the epiblast reaching about 15,000 cells by headfold/early somite
stage (Hogan et al., 1994). By contrast our EBs start out as
aggregated spheres of 500 cells and grow about 10 fold over 7
days. In a blastocyst the amount of migration for any given cell
required to create a blastocoelic layer of primitive endoderm is
only 1–2 exchanges of cell position. But in a 500 cell EB, which is
typical of the size range used by other investigators, many more
exchanges of position would be required to reach the surface. The
thermodynamic advantage, in terms of greater stability of the
aggregate (Foty and Steinberg, 2005), will not be achieved by an
isolated endoderm cell moving toward the surface since it will
remain surrounded on all sides by iPS cells. It would however be
achieved by the formation of aggregates of endoderm internally.
The reason that the pre-differentiated ES and iPS cells do form an
external layer of endoderm is probably that the sorting takes
place in the hours after centrifugation when the EB is only a few
cells thick, and before it has retracted into a sphere.
Another respect in which EBs are not like embryos is that their
internal structure is much more disorganized. In general our
results are quite comparable to those of (Leahy et al., 1999),
perhaps the most comprehensive previous study of EB structure
using early developmental markers. They saw patches of Nodal
and Bra from about 4 days of EB development and of Nkx2.5,
a cardiac marker, from about 6 days. The resolution of their 35S-in
situs is not as good as that which can be achieved with modern
techniques but the overall results look similar. There is also
a more recent account indicating a discrete principal body axis,
based on the use of a Wnt-beta-catenin reporter system (Ten
Berge et al., 2008). While these studies have laid stress on the
discreteness of the gene expression patches observed, in reality it
is more of a diffuse cloud, surrounded by scattered single cells
expressing the relevant markers, as is clearly apparent in our
Figs. 5 and S4. We do see discrete masses of cardiac tissue by days
7–8 (Fig. 6 and S4), although these are always multiple patches
without the morphology of a heart. So our conclusion is that,
although EBs do follow a similar time course of development to
normal embryos, the spatial organization is much more disorga-
nized, and they are more like mosaics of many mini-regions of
embryo rather than integrated body plans.In addition to the effect of size the disorganized structure of
EBs may be due to the relatively homogeneous external environ-
ment. Our EBs are suspended in medium, whereas the embryo has
a highly asymmetrical environment. In the embryo the epiblast is
in close contact with signaling centers in the anterior visceral
endoderm, emitting inhibitors of Wnt and Nodal (Perea-Gomez
et al., 2002; Thomas and Beddington, 1996; Varlet et al., 1997),
and the posterior visceral endoderm, emitting Wnt3 (Rivera-Pe´rez
and Magnuson, 2005). In general developmental systems display
a lot of symmetry-breaking processes in which small perturba-
tions bias delicately poised cell populations to develop down
particular pathways, often in a mutually autocatalytic manner.
If such processes can generate a single predictable embryonic axis
in a small group of cells surrounded by speciﬁc signaling centers,
it is not surprising that a large mass of cells in a uniform
environment will generate many small regions of pattern in a
disorganized manner.
We expect that the Oct4 reporter system that we describe here
will allow for many new kinds of study on embryoid bodies. These
will include the effects of aggregate size, the effects of different
culture media and substrates, and the effects of speciﬁc
differentiation-inducing treatments. We expect that this
approach will help to inform the design of the differentiation
protocols that are currently used to make human cells for
therapeutic transplantation, and make these protocols more
efﬁcient and reliable. Moreover the system can also be used to
study the development and organization of teratomas in vivo,
as administration of tamoxifen to the hosts will label green those
cells in the teratoma that are currently expressing Oct4. The
principles governing the development of teratomas, and the role
of Oct4 in the process, are poorly understood, and a study of this
type is currently underway in our lab.Acknowledgments
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